CFO Kathleen Bloch retires, stays as Interim CFO under consulting agreement through Dec 2025

Cytosorbents Corp

Bloch retired as CFO effective March 31, 2023, but will serve as Interim CFO under a Consulting Agreement.
Consulting rate: $335/hour, expected 20 hours/week; agreement lasts until Dec 31, 2025 unless terminated earlier.
Awarded 20,000 stock options at $3.37/share (3/31/23 closing price) with 10-year term; existing RSUs continue vesting.
Bloch provides customary CFO services; may be terminated by either party with 14 days' notice.

item 1.01 item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Kathleen P. Bloch

Chief Financial Officer

CTSO · Cytosorbents Corp

Effective: 2023-03-31
Filed: April 6, 2023, 7:59 PM ET

Ms. Kathleen P. Bloch retired from her role as Chief Financial Officer of CytoSorbents Corporation (the “ Company ”), effective as of March 31, 2023.

Appointed (interim)

Kathleen P. Bloch

Interim Chief Financial Officer

CTSO · Cytosorbents Corp

Effective: 2023-03-31
Filed: April 6, 2023, 7:59 PM ET

Ms. Bloch will serve as a consultant to the Company and as the Company’s Interim Chief Financial Officer.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Kathleen P. Bloch retired as Chief Financial Officer at Cytosorbents Corp.

Action: retired
Role: Chief Financial Officer

Exact text from the filing

Ms. Kathleen P. Bloch retired from her role as Chief Financial Officer of CytoSorbents Corporation (the “ Company ”), effective as of March 31, 2023.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Kathleen P. Bloch was appointed as Interim Chief Financial Officer at Cytosorbents Corp.

Action: appointed
Role: Interim Chief Financial Officer

Exact text from the filing

Ms. Bloch will serve as a consultant to the Company and as the Company’s Interim Chief Financial Officer.

View on SEC.gov

Cytosorbents Corp filing history →

Source: SEC EDGAR

accession 0001104659-23-042706

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.